BackNAYA Biosciences Common Stock Overview

NAYA Biosciences Common Stock Total Revenue

Revenue analysis for IVF.

Quarterly Revenue

$5.20M
↓ 99.92% YoY

As of Dec 2025

Annual Revenue (TTM)

$5.26B
↓ 19.43% YoY

Trailing 12 months ending Dec 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin